-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Szcn+fWA41A5aChJSWy781Godj8TySqiZUpwAZgv16D6AuPMmmmoiOqyX7A9GCKD 2Uc8DXWueM8n36UyA240pw== /in/edgar/work/20000612/0000950133-00-002537/0000950133-00-002537.txt : 20000919 0000950133-00-002537.hdr.sgml : 20000919 ACCESSION NUMBER: 0000950133-00-002537 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000612 GROUP MEMBERS: BB BIOTECH AG GROUP MEMBERS: BIOTECH GROWTH S.A. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: VIROLOGIC INC CENTRAL INDEX KEY: 0001094961 STANDARD INDUSTRIAL CLASSIFICATION: [8734 ] IRS NUMBER: 943234479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-59123 FILM NUMBER: 653440 BUSINESS ADDRESS: STREET 1: 270 EAST GRAND AVE. CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6506351100 MAIL ADDRESS: STREET 1: 270 EAST GRAND AVENUE CITY: SAN FRANCISCO STATE: CA ZIP: 94080 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STANDARD INDUSTRIAL CLASSIFICATION: [0000 ] STATE OF INCORPORATION: DC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: C/O BAKER & MCKENZIE STREET 2: 815 CONNECTICUT AVENUE NW CITY: WASHINGTON STATE: DC ZIP: 20006 BUSINESS PHONE: 2028351882 MAIL ADDRESS: STREET 1: C/O BAKER & MCKENZIE STREET 2: 815 CONNECTICUT AVENUE NW CITY: WASHINGTON STATE: DC ZIP: 20006 SC 13G 1 0001.txt BB BIOTECH AG 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. ___________)* VIROLOGIC INC. - ------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, $0.001 PAR VALUE PER SHARE - ------------------------------------------------------------------------------- (Title of Class of Securities) 92823 R201 - ------------------------------------------------------------------------------- (CUSIP Number) MAY 2, 2000 - ------------------------------------------------------------------------------- (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ X ] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) 2 CUSIP No. 92823 R201 - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). BB BIOTECH AG - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization SWITZERLAND - -------------------------------------------------------------------------------- Number of 5. Sole Voting Power Shares Bene- ficially -0- Owned by Each Reporting ------------------------------------------------------------- Person With: 6. Shared Voting Power 3,804,710(1) ------------------------------------------------------------- 7. Sole Dispositive Power -0- ------------------------------------------------------------- 8. Shared Dispositive Power 3,804,710(1) - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 3,804,710(1) 10. Check if the Aggregate Amount in Row (11) Excludes Certain shares 11. Percent of Class Represented by amount in Row (11) 19.1% - -------------------------------------------------------------------------------- 12. Type of Reporting Person (See Instructions) HC, CO - -------------------------------------------------------------------------------- Page 2 of 9 pages 1. Includes 199,705 shares of Common Stock issuable upon the exercise of warrants. 3 CUSIP No. 92823 R201 - -------------------------------------------------------------------------------- 1. Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). BIOTECH GROWTH S.A. - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (a) (b) - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization PANAMA - -------------------------------------------------------------------------------- Number of 5. Sole Voting Power Shares Bene- ficially -0- Owned by Each Reporting ------------------------------------------------------------- Person With: 6. Shared Voting Power 3,804,710(1) ------------------------------------------------------------- 7. Sole Dispositive Power -0- ------------------------------------------------------------- 8. Shared Dispositive Power 3,804,710(1) - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 3,804,710(1) 10. Check if the Aggregate Amount in Row (11) Excludes Certain shares 11. Percent of Class Represented by amount in Row (11) 19.1% - -------------------------------------------------------------------------------- 12. Type of Reporting Person CO - -------------------------------------------------------------------------------- Page 3 of 9 pages 1. Includes 199,705 shares of Common Stock issuable upon the exercise of warrants. 4 ITEM 1. (a) Name of Issuer VIROLOGIC INC. (b) Address of Issuer's Principal Executive Offices 270 EAST GRAND AVE. SAN FRANCISCO, CA 94080 ITEM 2. (a) Name of Person Filing BB BIOTECH AG ("BB BIOTECH") BIOTECH GROWTH S.A. ("BIOTECH GROWTH") (b) Address of Principal Business Office or, if none, Residence BB BIOTECH BIOTECH GROWTH VORDERGASSE 3 SWISS BANK TOWER 8300 SCHAFFHAUSEN REPUBLIC OF PANAMA CH/SWITZERLAND (c) Citizenship SEE ITEM NO. 4 OF COVER PAGES. (d) Title of Class of Securities COMMON STOCK, PAR VALUE $0.001 PER SHARE (e) CUSIP Number 92823 R201 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTIONS 240.13D-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). Page 4 of 9 pages 5 (d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [ ] An investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with Section 240.13d-1(b)(1)(ii)(J). ITEM 4. OWNERSHIP Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 3,804,710(1) (b) Percent of class: 19.1% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote -0- (ii) Shared power to vote or to direct the vote 3,804,710(1) (iii) Sole power to dispose or to direct the disposition of -0- (iv) Shared power to dispose or to direct the disposition of 3,804,710(1) Page 5 of 9 pages 1. Includes 199,705 shares of Common Stock issuable upon the exercise of warrants. 6 ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.[ ] ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Not applicable. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY This statement is filed jointly by BB Biotech and Biotech Growth. Biotech Growth is a wholly-owned subsidiary of BB Biotech. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP Not applicable. ITEM 9. Not applicable. ITEM 10. CERTIFICATION By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 6 of 9 pages 7 SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. BB BIOTECH AG Date: June 10, 2000 By: /s/ ANDERS HOVE ------------------------- Name: ANDERS HOVE ------------------------ Title: SIGNATORY AUTHORITY ------------------------ Date: June 10, 2000 By: /s/ DUBRAVKA RACNJAK ------------------------- Name: DUBRAVKA RACNJAK ------------------------ Title: SIGNATORY AUTHORITY ------------------------ BIOTECH GROWTH S.A. Date: June 10, 2000 By: /s/ ANDERS HOVE ------------------------- Name: ANDERS HOVE ------------------------ Title: SIGNATORY AUTHORITY ------------------------ Date: June 10, 2000 By: /s/ DUBRAVKA RACNJAK ------------------------- Name: DUBRAVKA RACNJAK ------------------------ Title: SIGNATORY AUTHORITY ------------------------ Page 7 of 9 pages 8 EXHIBIT INDEX Exhibit 1: Agreement by and between BB Biotech and Biotech Growth with respect to the filing of this disclosure statement. Page 8 of 9 pages 9 JOINT FILING AGREEMENT We, the undersigned, hereby express our agreement that the attached Schedule 13G (including all amendments thereto) is filed on behalf of each of the undersigned. BB BIOTECH AG Date: June 12, 2000 By: /s/ Anders Hove --------------------------- Name: Anders Hove --------------------------- Signatory Authority Date: June 12, 2000 By: /s/ D. Racnjak --------------------------- Name: D. Racnjak --------------------------- Signature Authority BIOTECH GROWTH, S.A. Date: June 12, 2000 By: /s/ Anders Hove --------------------------- Name: Anders Hove --------------------------- Signatory Authority Date: June 12, 2000 By: /s/ D. Racnjak --------------------------- Name: D. Racnjak --------------------------- Signatory Authority Page 9 of 9 pages -----END PRIVACY-ENHANCED MESSAGE-----